KIMBERLY RORICK: Open Payments
NPI 1003579004 · BINGHAM FARMS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 88 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,671 · 2025 $1,570
Food & beverage: $1,570
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $364 |
| Axsome Therapeutics, Inc. | 13 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $144 |
| Lundbeck LLC | 7 | $138 |
| Janssen Pharmaceuticals, Inc | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| Supernus Pharmaceuticals, Inc. | 5 | $80 |
| Tris Pharma Inc | 3 | $56 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $44 |
Products named: ARISTADA, Auvelity, REXULTI, CAPLYTA, SPRAVATO, Qelbree, Dyanavel XR, INGREZZA.
Industry payments across MI — which companies pay providers there.
